ERBB2 c.41_42delinsAG ;(p.A14E)

Variant ID: 17-37856532-CC-AG

NM_004448.2(ERBB2):c.41_42delinsAG;(p.A14E)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer.

Bmc Cancer
Soleimani Dodaran, Maryam M; Borgoni, Simone S; Sofyalı, Emre E; Verschure, Pernette J PJ; Wiemann, Stefan S; Moerland, Perry D PD; van Kampen, Antoine H C AHC
Publication Date: 2020-07-19

Variant appearance in text: HER2: A14E
PubMed Link: 32684154
Variant Present in the following documents:
  • Main text
View BVdb publication page



Comparison of outcomes between metaplastic and triple-negative breast cancer patients.

Breast (Edinburgh, Scotland)
Polamraju, Praveen P; Haque, Waqar W; Cao, Kevin K; Verma, Vivek V; Schwartz, Mary M; Klimberg, V Suzanne VS; Hatch, Sandra S; Niravath, Polly P; Butler, E Brian EB; Teh, Bin S BS
Publication Date: 2020-02

Variant appearance in text: HER2: A14E
PubMed Link: 31675684
Variant Present in the following documents:
  • Main text
View BVdb publication page